Table 1.
Participant information and clinicopathological characteristics
| Group | GC patients (n=148) | P* | EJA patients (n=59) | P* | Normal controls (n=148) |
|---|---|---|---|---|---|
| Age (years) | |||||
| Mean ± SD | 58 ±11 | 0.899 | 63 ±10 | 0.02 | 58 ±11 |
| Range | 26-81 | 22-81 | 29-84 | ||
| Gender | |||||
| Male | 99 | 0.714 | 45 | 0.113 | 96 |
| Female | 49 | 14 | 52 | ||
| Smoke | |||||
| Yes | 66 | 13 | |||
| No | 82 | 42 | |||
| Unknown | 0 | 4 | |||
| Depth of tumor invasion | |||||
| Tis | 0 | 2 | |||
| T1 | 14 | 3 | |||
| T2 | 5 | 2 | |||
| T3 | 28 | 2 | |||
| T4 | 94 | 40 | |||
| Unknown | 7 | 10 | |||
| Lymph node metastasis | |||||
| N0 | 43 | 14 | |||
| N1 | 25 | 8 | |||
| N2 | 41 | 7 | |||
| N3 | 31 | 20 | |||
| Unknown | 8 | 10 | |||
| Distant metastasis | |||||
| Yes | 19 | 14 | |||
| No | 123 | 35 | |||
| Unknown | 6 | 10 | |||
| TNM stage | |||||
| 0 | 0 | 2 | |||
| Ⅰ | 15 | 5 | |||
| Ⅱ | 31 | 6 | |||
| Ⅲ | 68 | 21 | |||
| Ⅳ | 31 | 15 | |||
| Unknown | 3 | 10 | |||
*Compared with normal controls. GC: Gastric cancers; EJA: Esophagogastric junction adenocarcinomas.